161 related articles for article (PubMed ID: 32735108)
1. Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis.
Kim J; Kim JY; Oh EH; Yoo C; Park IJ; Yang DH; Ryoo BY; Ryu JS; Hong SM
Am J Surg Pathol; 2020 Nov; 44(11):1496-1505. PubMed ID: 32735108
[TBL] [Abstract][Full Text] [Related]
2. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis.
Kim JY; Kim KS; Kim KJ; Park IJ; Lee JL; Myung SJ; Park Y; Park YS; Yu CS; Kim JC; Yu E; Jang HJ; Hong SM
Am J Surg Pathol; 2015 May; 39(5):632-43. PubMed ID: 25724002
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors.
Tsukamoto S; Fujita S; Yamaguchi T; Yamamoto S; Akasu T; Moriya Y; Taniguchi H; Shimoda T
Int J Colorectal Dis; 2008 Nov; 23(11):1109-13. PubMed ID: 18594844
[TBL] [Abstract][Full Text] [Related]
4. Well-differentiated rectal neuroendocrine tumors: analysis of histology, including insulinoma-associated protein 1 expression, and biologic behavior, involving a large cohort of 94 cases.
Sappenfield R; Gonzalez IA; Cao D; Chatterjee D
Hum Pathol; 2020 Oct; 104():66-72. PubMed ID: 32763255
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis.
Kang HS; Kwon MJ; Kim TH; Han J; Ju YS
Pathol Res Pract; 2019 Nov; 215(11):152642. PubMed ID: 31585816
[TBL] [Abstract][Full Text] [Related]
6. Rectal Neuroendocrine Tumor with Synchronous Pancreatic Metastasis: A Case Report.
Masuoka Y; Furukawa D; Yazawa N; Izumi H; Yamada M; Mashiko T; Saito G; Okada K; Tanaka A; Suzuki T; Sadahiro S; Hirabayashi K; Nakagohri T
Tokai J Exp Clin Med; 2018 Jul; 43(2):38-44. PubMed ID: 29961930
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
[TBL] [Abstract][Full Text] [Related]
8. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Impact of Peptide Hormonal Expression in Rectal Neuroendocrine Tumors.
Kim J; Yang DH; Jung H; Cho H; Jang HJ; Yoo C; Park IJ; Ryoo BY; Ryu JS; Hong SM
Arch Pathol Lab Med; 2023 Jul; 147(7):797-807. PubMed ID: 36191342
[TBL] [Abstract][Full Text] [Related]
10. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
Choi JS; Kim MJ; Shin R; Park JW; Heo SC; Jeong SY; Park KJ; Ryoo SB
Ann Surg Oncol; 2024 Apr; 31(4):2414-2424. PubMed ID: 38194045
[TBL] [Abstract][Full Text] [Related]
11. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.
Kim JY; Kim J; Kim YI; Yang DH; Yoo C; Park IJ; Ryoo BY; Ryu JS; Hong SM
Sci Rep; 2024 Feb; 14(1):4047. PubMed ID: 38374188
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
[TBL] [Abstract][Full Text] [Related]
14. PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.
Jernman J; Kallio P; Hagström J; Välimäki MJ; Haapasalo H; Alitalo K; Arola J; Haglund C
Virchows Arch; 2015 Sep; 467(3):279-84. PubMed ID: 26063416
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters.
; Sohn JH; Cho MY; Park Y; Kim H; Kim WH; Kim JM; Jung ES; Kim KM; Lee JH; Chan HK; Park DY; Joo M; Kim S; Moon WS; Kang MS; Jin SY; Kang YK; Yoon SO; Han H; Choi E
Cancer Res Treat; 2015 Oct; 47(4):813-22. PubMed ID: 25715764
[TBL] [Abstract][Full Text] [Related]
16. Colon and Rectal Neuroendocrine Tumors: Are They Really One Disease? A Single-Institution Experience over 15 Years.
Broecker JS; Ethun CG; Postlewait LM; Le N; McInnis M; Russell MC; Sullivan P; Kooby DA; Staley CA; Maithel SK; Cardona K
Am Surg; 2018 May; 84(5):717-726. PubMed ID: 29966574
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors.
Cha JH; Jung DH; Kim JH; Youn YH; Park H; Park JJ; Um YJ; Park SJ; Cheon JH; Kim TI; Kim WH; Lee HJ
Sci Rep; 2019 Mar; 9(1):4911. PubMed ID: 30894571
[TBL] [Abstract][Full Text] [Related]
18. Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cm.
Mirkin KA; Hollenbeak CS; Wong J
J Surg Res; 2017 May; 211():206-214. PubMed ID: 28501118
[TBL] [Abstract][Full Text] [Related]
19. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion.
Nam SJ; Kim BC; Chang HJ; Jeon HH; Kim J; Kim SY
Gut Liver; 2022 Mar; 16(2):228-235. PubMed ID: 34552040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
